ESMO 2024: Organ Preservation More Likely With Long- vs Short-Course Chemoradiotherapy in Patients With Rectal Cancer
However, distant recurrence, disease-free survival, and overall survival similar for the two regimens at two years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.